C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
12/2004
12/16/2004	WO2003063797A8 Cycloalkyl inhibitors of potassium channel function
12/16/2004	US20040254206 herbicides
12/16/2004	US20040254203 Methods and compositions utilizing quinazolinones
12/16/2004	US20040254183 Pyrazolo[3,4-d]pyrimidines inhibiting h. pylori infections
12/16/2004	US20040254182 Enhanced propertied pharmaceuticals
12/16/2004	US20040254141 Therapy for hepatitis B virus infection ; antiproliferative agents; antitumor agents; anticancer agents
12/16/2004	CA2527313A1 N-alkynyl-2-(substituted aryloxy) alkylthioamide derivatives as fungicides
12/16/2004	CA2526995A1 Bicyclic heterocycles, drugs containing said compounds, the use thereof and method for preparing the same
12/15/2004	EP1486489A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
12/15/2004	EP1486210A1 Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis
12/15/2004	EP1485472A2 Crystal structure of an aurora kinase catalytic domain, and uses thereof
12/15/2004	EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485365A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485354A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485353A1 New inhibitors of histone deacetylase
12/15/2004	EP1485348A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485107A1 Phospholipids as caspase inhibitor prodrugs
12/15/2004	EP1485101A1 Non-sedating barbituric acid derivatives
12/15/2004	EP1485099A1 Inhibitors of histone deacetylase
12/15/2004	EP1485089A1 Combination treatments for chemokine-mediated diseases
12/15/2004	EP1484971A1 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces
12/15/2004	EP1263711B1 Novel use of phenylheteroalkylamine derivatives
12/15/2004	EP0884051B1 Cancerous metastasis inhibitors containing uracil derivatives
12/15/2004	CN1555367A 3-substituted-4-pyrimidone derivatives
12/15/2004	CN1555358A CCR-3 receptor antagonists v
12/15/2004	CN1554649A Metabotropic glutamate receptor antagonists for treating central nervous system diseases
12/15/2004	CN1179952C Pyrimidine-4-one derivatives as LDL-PLA2 inhibitors
12/14/2004	US6831199 Pyrimidine compounds and derivatives thereof
12/14/2004	US6831193 Trisubstituted-N-[(1S)-1,2,3,4-Tetrahydro-1-naphthalenyl]benzamides which inhibit P2X3 and P2X2/3 containing receptors
12/14/2004	US6831085 Methods and compositions utilizing quinazolinones
12/14/2004	US6831080 Cinnamide derivatives as KCNQ potassium channel modulators
12/14/2004	CA2235146C Herbicidal sulfonamides
12/14/2004	CA2180867C Monomeric diols and phosphate linked oligomers formed therefrom
12/09/2004	WO2004106308A1 Quinazolines and pyrido [3,4-d] pyrimidines as receptor tyrosine kinase inhibitors
12/09/2004	WO2004106296A2 Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators
12/09/2004	WO2004105765A1 Macrocyclic quinazoline derivatives as antiproliferative agents
12/09/2004	WO2004105754A1 Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity
12/09/2004	WO2004069794A9 New arylpiperazinyl compounds
12/09/2004	WO2004061084A8 Modulation of protein functionalities
12/09/2004	WO2004050639A3 5-nitroso-6-piperazinyl-pyrimidine derivatives for treating ischemia
12/09/2004	WO2003104206A3 Herbicidally active heterocyclylalkynes
12/09/2004	US20040249153 For therapy of inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors
12/09/2004	US20040249152 Activation of the carboxyl function of a CNA monomer building block, subsequent esterification of this monomer building block with a free hydroxyl function,thereafter assembly of the oligomer by repetitive cycles starting from elimination of the protective group
12/09/2004	US20040248916 Pyrimidine derivatives as selective inhibitors of cox-2
12/09/2004	US20040248907 reacting 4,6-dichloro-5-nitropyrimidine with acyclic carboxy amines, then cyclization of the intermediates to form cellular adhesion inhibitors
12/09/2004	US20040248890 Voltage gated sodium and calcium channel inhibitors
12/09/2004	US20040248872 Safe for agricultural or gardening use; effective against insects and mammals
12/09/2004	US20040248740 for controlling undesirable plants
12/09/2004	US20040248221 Using transgenic tumor cells as models for antitumor agent efficacy; tissue targeted therapy and antiproliferative agents
12/09/2004	US20040247621 Combination therapy using a synergistic mixture of mechlorethamine, nitrogen mustard N-oxide, melphalan, uramustin, ifosfamide, chlorambucil, or cyclophosphamide and an anti-interleukin-6 receptor antibody; anticarcinogenic agents
12/09/2004	CA2527168A1 Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity
12/09/2004	CA2527017A1 Quinazolines and pyrido [3,4-d] pyrimidines as receptor tyrosine kinase inhibitors
12/08/2004	EP1483259A1 Pyrimidines as novel openers of potassium ion channels
12/08/2004	EP1483257A1 Quinazoline compounds useful in therapy
12/08/2004	EP1483249A1 Pyrimidine compounds and their use as pesticides
12/08/2004	EP1483248A1 Halobenzyl substituted phenylaceto esters and amides and use thereof for prevention of harmful organisms
12/08/2004	EP1483247A2 Aryl substituted pyrimidines and the use thereof
12/08/2004	EP1483242A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
12/08/2004	EP1482940A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
12/08/2004	EP1482924A2 Cathepsin cysteine protease inhibitors
12/08/2004	CN1553906A VARIOLIN derivatives and their use as antitumor agents
12/08/2004	CN1553901A New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
12/08/2004	CN1553899A Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor and medicinal composition containing the same
12/08/2004	CN1553888A Biphenylene compounds
12/08/2004	CN1178993C Orange and deep red mixture of reactive dyes
12/08/2004	CN1178932C Amide derivatives
12/08/2004	CN1178922C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
12/08/2004	CN1178921C Preparation of sulfonamides
12/08/2004	CN1178905C Novel peptide derivative
12/08/2004	CN1178880C Application of ring enamine as light stability agent
12/07/2004	US6828324 Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT1A activity
12/07/2004	US6828320 Heterocyclic compounds
12/07/2004	US6828315 1-Amino triazoloc4,3-a! quinazoline-5-ones and/or -5-thiones inhibiting phosphodiesterase IV
12/07/2004	US6827876 Using alpha, alpha -difluorocyclohexylidene derivative as starting material to obtain difluoromethyl ether derivative
12/02/2004	WO2004103979A1 Method for producing n-(2-amino-4,6-dichloropyrimidine-5-yl)formamide
12/02/2004	WO2004103978A1 2-substituted pyrimidines
12/02/2004	WO2004103977A2 Process for the preparation of pyrimidine derivatives
12/02/2004	WO2004058174A3 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/02/2004	WO2004054986A3 Process for the preparation of pyrimidine compounds
12/02/2004	US20040242877 Reacting malondiimate with diketene; chemical intermediate for agriculture products
12/02/2004	US20040242876 Reacting malondiimidate with ketoester
12/02/2004	US20040242875 Forming pyrimidinone compounds
12/02/2004	US20040242871 Nitric oxide synthease inhibitors; antiinflamamtory agents; analgesics; inflamamtory bowel disorders; antiarthritic agents;
12/02/2004	US20040242868 Controlling cytokines; antiinflammatory agents; rheumatic disoreders; skin disorders; respiratory system disorders; Alzheimer's disease; Parkinson's disease; Huntington"s disease ; amyotrophic lateral sclerosis
12/02/2004	US20040242614 Pharmaceutically active compounds and methods of use thereof
12/02/2004	US20040242613 Pyrimidine derivatives useful as inhibitors of PKC-theta
12/02/2004	US20040242611 Novel phenylamino-pyrimidines and uses thereof
12/02/2004	US20040242608 Substituted pyrimidinones
12/02/2004	US20040242607 formylation and methylation of a 1-(6-substituted pyrimidin-4-yloxy)-2-(2-alkoxy-2-lithiooxyvinyl)benzene
12/02/2004	US20040242606 Anti-cancer cyclopenta (g)quinazoline compounds
12/02/2004	US20040242604 Substituted heterocycles for the treatment of abnormal cell growth
12/02/2004	US20040242603 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor and medicinal composition containing the same
12/02/2004	US20040242578 Pyrimidineamines as angiogenesis modulators
12/02/2004	US20040242574 Anticancer agents; antiarthritic agents
12/02/2004	US20040242572 New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
12/02/2004	US20040242568 Dipeptidyl peptidase inhibitors
12/02/2004	US20040242566 Dipeptidyl peptidase inhibitors
12/02/2004	US20040242533 such as 5-iodo-O6-5'-cyclo-5,6-dihydro-3'-azido-3'-deoxythymidine for prophylaxis or diagnosis of viral diseases caused by hepatitis virus, herpes viruses such as Epstein-Barr virus
12/02/2004	CA2525762A1 2-substituted pyrimidines

1 ... 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 ... 427